Friday, October 2, 2020

Drug found to correct gene defect that causes immune-driven gut leakiness

Researchers have found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can repair permeability defects in the intestine.

from Top Health News -- ScienceDaily https://ift.tt/3jqltj0
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

One tiny mutation may explain how bat viruses become human threats

Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with...